Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-280384
Filing Date
2025-11-13
Accepted
2025-11-13 16:52:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d34136d424b5.htm 424B5 519899
2 GRAPHIC g34136g00r00.jpg GRAPHIC 42480
3 GRAPHIC g34136g01g01.jpg GRAPHIC 46536
  Complete submission text file 0001193125-25-280384.txt   630235
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650) 822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278246 | Film No.: 251479405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)